GAMMA Investing’s Surmodics SRDX Stock Holding History

GAMMA Investing’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-135	Closed	-$4.04K	–	4134
2025 Q3	$4.04K	Buy	135 +109	+419%	+$3.64K	﹤0.01%	3254
2025 Q2	$772	Buy	+26	New	+$749	﹤0.01%	3582
2025 Q1	–	Sell	-5	Closed	-$198	–	3878
2024 Q4	$198	Hold	5	–	–	﹤0.01%	3706
2024 Q3	$194	Hold	5	–	–	﹤0.01%	3502
2024 Q2	$210	Sell	5 -15	-75%	-$512	﹤0.01%	3332
2024 Q1	$587	Buy	+20	New	+$638	﹤0.01%	3075

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's SRDX Position: Q4 2025 in Review

GAMMA Investing sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 135 shares — an estimated $4.04K sold.

GAMMA Investing first reported a position in SRDX in Q1 2024 and held it in 6 quarters. The position peaked at $4.04K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

GAMMA Investing reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
GAMMA Investing sold 135 Surmodics shares in Q4 2025, an estimated $4.04K.
GAMMA Investing first reported a position in Surmodics in Q1 2024 and held it in 6 quarters.
GAMMA Investing's Surmodics position peaked at $4.04K in Q3 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.